An Oncofetal Protein IMP3, a New Molecular Marker for the Detection of Dysplasia and Carcinoma of the Gallbladder

被引：0
|
作者：
Stockl, T. [1 ]
Jiang, Z. [1 ]
机构：
[1] UMass Mem Med Ctr, Worcester, MA USA
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
706
引用
收藏
页码：169A / 169A
页数：1
相关论文
共 50 条
  • [31] The RNA binding protein IMP3: A noval molecular marker to predict aggressive superficial urothelial carcinoma of the bladder
    Sitnikova, L.
    Liu, Q.
    Mendese, G.
    Woda, B. A.
    Lu, D.
    Rock, K. L.
    Jiang, Z.
    MODERN PATHOLOGY, 2007, 20 : 177A - 177A
  • [32] The RNA binding protein IMP3: A noval molecular marker to predict aggressive superficial urothelial carcinoma of the bladder
    Sitnikova, L.
    Liu, Q.
    Mendese, G.
    Woda, B. A.
    Lu, D.
    Rock, K. L.
    Jiang, Z.
    LABORATORY INVESTIGATION, 2007, 87 : 177A - 177A
  • [33] Oncofetal Protein IMP3, a New Biomarker To Distinguish Malignant Mesothelioma from Reactive Mesothelial Proliferation
    Shi, M.
    Fraire, A.
    Chu, P.
    Cornejo, K.
    Woda, B.
    Jiang, Z.
    LABORATORY INVESTIGATION, 2011, 91 : 424A - 424A
  • [34] Oncofetal (IMP3) and Stem Cell Markers in Primary and Metastatic Renal Cell Carcinoma
    Sher, K.
    Rao, P.
    Chen, G.
    Guoit, M. C.
    Fahmy, M. A.
    Tanguay, S.
    Aldape, K.
    Sircar, K.
    MODERN PATHOLOGY, 2009, 22 : 193A - 193A
  • [35] Oncofetal Protein IMP3, a New Biomarker To Distinguish Malignant Mesothelioma from Reactive Mesothelial Proliferation
    Shi, M.
    Fraire, A.
    Chu, P.
    Cornejo, K.
    Woda, B.
    Jiang, Z.
    MODERN PATHOLOGY, 2011, 24 : 424A - 424A
  • [36] Oncofetal Proteins IMP3, Glypican-3 and TPBG Expression in Urothelial Carcinoma of the Bladder
    Khani, F.
    Xylinas, E.
    Cha, E.
    Volkmer, B.
    Kluth, L.
    Scherr, D. S.
    Rubin, M. A.
    Mosquera, J. M.
    Hautmann, R. E.
    Kuefer, R.
    Shariat, S. F.
    Robinson, B. D.
    MODERN PATHOLOGY, 2013, 26 : 225A - 226A
  • [37] Oncofetal Proteins IMP3, Glypican-3 and TPBG Expression in Urothelial Carcinoma of the Bladder
    Khani, F.
    Xylinas, E.
    Cha, E.
    Volkmer, B.
    Kluth, L.
    Scherr, D. S.
    Rubin, M. A.
    Mosquera, J. M.
    Hautmann, R. E.
    Kuefer, R.
    Shariat, S. F.
    Robinson, B. D.
    LABORATORY INVESTIGATION, 2013, 93 : 225A - 226A
  • [38] Oncofetal (IMP3) and Stem Cell Markers in Primary and Metastatic Renal Cell Carcinoma
    Sher, K.
    Rao, P.
    Chen, G.
    Guoit, M. C.
    Fahmy, M. A.
    Tanguay, S.
    Aldape, K.
    Sircar, K.
    LABORATORY INVESTIGATION, 2009, 89 : 193A - 193A
  • [39] IMP3, a novel oncofetal protein that differentiates between benign endosalpingiosis and metastatic adenocarcinomas
    Garcia, M. T.
    Ganjei-Azar, P.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S76 - S77
  • [40] An oncofetal protein, IMP3: A novel biomarker to predict of tumor progression in the low grade Ta urothelial carcinoma of the bladder
    Mohanty, S. K.
    Lu, D. I.
    Dresser, K.
    Jiang, Z.
    MODERN PATHOLOGY, 2008, 21 : 171A - 171A
12345